Qiming U.S. Ventures Management as of March 31, 2022
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Talaris Therapeutics | 27.1 | $29M | 2.9M | 9.84 | |
| Icosavax | 23.2 | $25M | 3.5M | 7.04 | |
| Jasper Therapeutics | 19.5 | $21M | 5.9M | 3.55 | |
| Kezar Life Sciences | 12.9 | $14M | 829k | 16.62 | |
| Ventyx Biosciences (VTYX) | 11.6 | $12M | 910k | 13.57 | |
| Elevation Oncology (ELEV) | 5.6 | $6.0M | 2.4M | 2.52 |
